Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

An immunologic portrait of cancer.

Ascierto ML, De Giorgi V, Liu Q, Bedognetti D, Spivey TL, Murtas D, Uccellini L, Ayotte BD, Stroncek DF, Chouchane L, Manjili MH, Wang E, Marincola FM.

J Transl Med. 2011 Aug 29;9:146. doi: 10.1186/1479-5876-9-146. Review.

2.

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Galon J, Angell HK, Bedognetti D, Marincola FM.

Immunity. 2013 Jul 25;39(1):11-26. doi: 10.1016/j.immuni.2013.07.008. Review.

3.

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Finn OJ.

Ann Oncol. 2012 Sep;23 Suppl 8:viii6-9. doi: 10.1093/annonc/mds256. Review.

4.

Disentangling the relationship between tumor genetic programs and immune responsiveness.

Bedognetti D, Hendrickx W, Ceccarelli M, Miller LD, Seliger B.

Curr Opin Immunol. 2016 Apr;39:150-8. doi: 10.1016/j.coi.2016.02.001. Epub 2016 Mar 9. Review.

PMID:
26967649
5.

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.

Becht E, Giraldo NA, Germain C, de Reyniès A, Laurent-Puig P, Zucman-Rossi J, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Adv Immunol. 2016;130:95-190. doi: 10.1016/bs.ai.2015.12.002. Epub 2016 Jan 29. Review.

PMID:
26923001
6.

Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

Bodey B, Siegel SE, Kaiser HE.

Anticancer Res. 1996 Mar-Apr;16(2):661-74. Review.

PMID:
8687112
7.

Tumor immunosurveillance in human cancers.

Mlecnik B, Bindea G, Pagès F, Galon J.

Cancer Metastasis Rev. 2011 Mar;30(1):5-12. doi: 10.1007/s10555-011-9270-7. Review.

8.

The immunologic constant of rejection.

Wang E, Worschech A, Marincola FM.

Trends Immunol. 2008 Jun;29(6):256-62. doi: 10.1016/j.it.2008.03.002. Epub 2008 May 3. Review.

PMID:
18457994
9.

[Intratumoral immune microenvironment and survival: the immunoscore].

Galon J, Bindea G, Mlecnik B, Angell H, Lagorce C, Todosi AM, Berger A, Pagès F.

Med Sci (Paris). 2014 Apr;30(4):439-44. doi: 10.1051/medsci/20143004020. Epub 2014 May 5. Review. French.

10.

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

Curigliano G, Criscitiello C, Esposito A, Fumagalli L, Gelao L, Locatelli M, Minchella I, Goldhirsch A.

Breast. 2013 Aug;22 Suppl 2:S96-9. doi: 10.1016/j.breast.2013.07.018. Review.

PMID:
24074802
11.

Oncology meets immunology: the cancer-immunity cycle.

Chen DS, Mellman I.

Immunity. 2013 Jul 25;39(1):1-10. doi: 10.1016/j.immuni.2013.07.012. Review.

13.

Natural immunity to cancer in humans.

Bindea G, Mlecnik B, Fridman WH, Pagès F, Galon J.

Curr Opin Immunol. 2010 Apr;22(2):215-22. doi: 10.1016/j.coi.2010.02.006. Epub 2010 Mar 6. Review.

PMID:
20207124
14.

The fundamental role of mechanical properties in the progression of cancer disease and inflammation.

Mierke CT.

Rep Prog Phys. 2014 Jul;77(7):076602. doi: 10.1088/0034-4885/77/7/076602. Epub 2014 Jul 9. Review.

PMID:
25006689
15.

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Sartor RB.

Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Review.

PMID:
8809232
16.

Shaping of an effective immune microenvironment to and by cancer cells.

Becht E, Goc J, Germain C, Giraldo NA, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Cancer Immunol Immunother. 2014 Oct;63(10):991-7. doi: 10.1007/s00262-014-1590-3. Epub 2014 Aug 12. Review.

PMID:
25112529
17.

Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.

Gingras I, Azim HA Jr, Ignatiadis M, Sotiriou C.

Clin Adv Hematol Oncol. 2015 Jun;13(6):372-82. Review.

PMID:
26352893
18.

Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms.

Demoulin S, Herfs M, Delvenne P, Hubert P.

J Leukoc Biol. 2013 Mar;93(3):343-52. doi: 10.1189/jlb.0812397. Epub 2012 Nov 7. Review.

PMID:
23136258
19.

Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.

Di Caro G, Castino GF, Bergomas F, Cortese N, Chiriva-Internati M, Grizzi F, Mantovani A, Marchesi F.

Int Rev Immunol. 2015 Mar;34(2):123-33. doi: 10.3109/08830185.2015.1018416. Review.

PMID:
25901857
20.

Supplemental Content

Support Center